Michael I. D’angelica

Michael I. D’angelica's AcademicInfluence.com Rankings

Medical

#2295

World Rank

#2710

Historical Rank

Oncology

#134

World Rank

#138

Historical Rank

medical Degrees

Michael I. D’angelica

Philosophy

#6689

World Rank

#9770

Historical Rank

Logic

#3817

World Rank

#5029

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Michael I. D’angelica Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael I. D’angelica's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

NCCN clinical practice guidelines in oncology: hepatobiliary cancers. (2009) (2154)
The International Position on Laparoscopic Liver Surgery: The Louisville Statement, 2008 (2009) (1353)
Actual 10-year survival after resection of colorectal liver metastases defines cure. (2007) (1031)
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. (2008) (959)
Intrahepatic Cholangiocarcinoma: Rising Frequency, Improved Survival, and Determinants of Outcome After Resection (2008) (690)
Patterns of Initial Recurrence in Completely Resected Gastric Adenocarcinoma (2004) (542)
Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection (2003) (462)
Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. (2010) (452)
Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma (2003) (414)
Gallbladder cancer (GBC): 10‐year experience at Memorial Sloan‐Kettering Cancer Centre (MSKCC) (2008) (385)
Operative Blood Loss Independently Predicts Recurrence and Survival After Resection of Hepatocellular Carcinoma (2009) (357)
Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Analysis of Clinicopathologic Features and Outcome (2004) (342)
Pasireotide for postoperative pancreatic fistula. (2014) (335)
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. (2006) (315)
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies (2018) (312)
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions (2014) (306)
Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades (2011) (297)
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention (2018) (272)
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone. (2016) (260)
Comparative genomic analysis of primary versus metastatic colorectal carcinomas. (2012) (257)
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. (2021) (257)
Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center. (2016) (252)
18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. (2008) (244)
Ablation of perivascular hepatic malignant tumors with irreversible electroporation. (2012) (236)
The Impact of Margins on Outcome After Hepatic Resection for Colorectal Metastasis (2007) (229)
Increased Use of Parenchymal-Sparing Surgery for Bilateral Liver Metastases From Colorectal Cancer Is Associated With Improved Mortality Without Change in Oncologic Outcome: Trends in Treatment Over Time in 440 Patients (2008) (228)
The Miami International Evidence-Based Guidelines on Minimally Invasive Pancreas Resection. (2019) (218)
Effect of Postoperative Morbidity on Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer (2008) (217)
Intraductal papillary neoplasm of the bile duct: A biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? (2012) (216)
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. (2017) (211)
A Selective Approach to the Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients (2006) (206)
Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. (2011) (205)
Outcome of patients with fibrolamellar hepatocellular carcinoma (2006) (200)
Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. (2009) (200)
Liver Cell Adenoma: A Multicenter Analysis of Risk Factors for Rupture and Malignancy (2009) (199)
Partial Hepatectomy for Metastases From Noncolorectal, Nonneuroendocrine Carcinoma (2005) (194)
Analysis of the Extent of Resection for Adenocarcinoma of the Gallbladder (2009) (194)
Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. (2005) (191)
Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. (2007) (187)
The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. (2012) (180)
Laparoscopic distal pancreatectomy: evolution of a technique at a single institution. (2010) (175)
Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic Cancer (2007) (175)
Combined Portal Vein Embolization and Neoadjuvant Chemotherapy As a Treatment Strategy for Resectable Hepatic Colorectal Metastases (2008) (175)
Distal pancreatectomy: a single institution's experience in open, laparoscopic, and robotic approaches. (2015) (174)
Lack of Evidence for Increased Operative Morbidity After Hepatectomy with Perioperative Use of Bevacizumab: A Matched Case-Control Study (2007) (172)
Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy (2010) (171)
Accurate Staging for Gallbladder Cancer: Implications for Surgical Therapy and Pathological Assessment (2011) (171)
Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma (2008) (170)
Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines (2017) (169)
Papillary Phenotype Confers Improved Survival After Resection of Hilar Cholangiocarcinoma (2005) (169)
BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer (2014) (167)
Solid Pseudopapillary Tumors of the Pancreas. Clinical Features, Surgical Outcomes, and Long-Term Survival in 45 Consecutive Patients from a Single Center (2011) (165)
A Nomogram for Predicting Disease-specific Survival After Hepatic Resection for Metastatic Colorectal Cancer (2008) (164)
Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis. (2014) (164)
Management of primary liver sarcomas (2007) (163)
Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. (2007) (156)
Outcome After Hepatectomy for Multiple (Four or More) Colorectal Metastases in the Era of Effective Chemotherapy (2007) (155)
Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control. (2017) (154)
Effect on Outcome of Recurrence Patterns After Hepatectomy for Colorectal Metastases (2011) (154)
Urgent need for a new staging system in advanced colorectal cancer. (2008) (151)
A Retrospective Comparison of Microwave Ablation vs. Radiofrequency Ablation for Colorectal Cancer Hepatic Metastases (2014) (149)
Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. (2016) (148)
Operative Drainage Following Pancreatic Resection: Analysis of 1122 Patients Resected Over 5 Years at a Single Institution (2013) (144)
The Role of Staging Laparoscopy in Hepatobiliary Malignancy: Prospective Analysis of 401 Cases (2003) (144)
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. (2009) (140)
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. (2019) (140)
Liver Resection for Metastatic Colorectal Cancer in Patients with Concurrent Extrahepatic Disease: Results in 127 Patients Treated at a Single Center (2009) (138)
Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. (2007) (137)
Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. (2009) (137)
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case–Control Study (2016) (135)
Regulatory T Cell Infiltration Predicts Outcome Following Resection of Colorectal Cancer Liver Metastases (2013) (132)
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma (2015) (131)
Hepatic Parenchymal Preservation Surgery: Decreasing Morbidity and Mortality Rates in 4,152 Resections for Malignancy (2014) (130)
Rates and Patterns of Recurrence for Percutaneous Radiofrequency Ablation and Open Wedge Resection for Solitary Colorectal Liver Metastasis (2007) (129)
Adequate Lymph Node Assessment for Extrahepatic Bile Duct Adenocarcinoma (2010) (129)
KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases (2014) (126)
Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma (2005) (124)
A Prospective Randomized Trial of Acute Normovolemic Hemodilution Compared to Standard Intraoperative Management in Patients Undergoing Major Hepatic Resection (2008) (123)
Laparoscopic versus Open Liver Resection: A Matched-Pair Case Control Study (2009) (122)
A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma (2014) (122)
A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. (2008) (120)
T Cell Infiltrate Predicts Long-Term Survival Following Resection of Colorectal Cancer Liver Metastases (2009) (120)
Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients (2003) (117)
Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone (2016) (117)
Actual 10‐year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? (2018) (116)
Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. (2015) (113)
Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. (2005) (113)
Clinical Significance of Intraoperative Bile Duct Margin Assessment for Hilar Cholangiocarcinoma (2008) (113)
A Matched Case-Control Study of Preoperative Biliary Drainage in Patients with Pancreatic Adenocarcinoma: Routine Drainage Is Not Justified (2009) (109)
Invasive Carcinoma Arising in Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Matched Control Study with Conventional Pancreatic Ductal Adenocarcinoma (2011) (105)
Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. (2008) (105)
Relationship Between Intraoperative Fluid Administration and Perioperative Outcome After Pancreaticoduodenectomy: Results of a Prospective Randomized Trial of Acute Normovolemic Hemodilution Compared With Standard Intraoperative Management (2010) (103)
Liver Resection for Metastatic Colorectal Cancer in the Presence of Extrahepatic Disease (2009) (103)
Surgical treatment of hepatocellular carcinoma: expert consensus statement. (2010) (103)
Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer (2011) (101)
Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. (2011) (101)
Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. (1997) (99)
Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. (2011) (99)
A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers (2012) (99)
Perihepatic Lymph Node Assessment in Patients Undergoing Partial Hepatectomy for Malignancy (2006) (98)
Laparoscopic Adrenalectomy for Isolated Adrenal Metastasis (2007) (98)
Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation (2013) (97)
Polypoid lesions of the gallbladder: diagnosis and followup. (2009) (97)
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 2.2019: Featured Updates to the NCCN Guidelines (2019) (96)
CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. (2011) (96)
Pancreatic Cyst Fluid and Serum Mucin Levels Predict Dysplasia in Intraductal Papillary Mucinous Neoplasms of the Pancreas (2010) (95)
Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis. (2017) (92)
Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. (2015) (92)
Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. (2013) (91)
Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models. (2016) (91)
Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. (2015) (90)
Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection (2016) (90)
Contemporary experience with postpancreatectomy hemorrhage: results of 1,122 patients resected between 2006 and 2011. (2012) (88)
Hepatobiliary cancers, version 2.2014. (2014) (88)
Response to Neoadjuvant Chemotherapy Does Not Predict Overall Survival for Patients With Synchronous Colorectal Hepatic Metastases (2009) (88)
Robotic Liver Resection: A Case-Matched Comparison (2016) (88)
Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. (2009) (87)
Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. (2004) (87)
Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. (2005) (86)
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. (2019) (86)
Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis (2018) (85)
Preoperative radiographic assessment of hepatic steatosis with histologic correlation. (2008) (85)
Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium (2018) (85)
Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. (2013) (84)
Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms (2008) (83)
Is Port Site Resection Necessary in the Surgical Management of Gallbladder Cancer? (2012) (83)
Predicting the Risk of Perioperative Transfusion for Patients Undergoing Elective Hepatectomy (2009) (83)
Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases (2018) (82)
Single-incision laparoscopic liver resection (2011) (82)
Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. (2014) (79)
Predicting Dysplasia and Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Development of a Preoperative Nomogram (2013) (79)
Biliary Self-Expandable Metal Stents Do Not Adversely Affect Pancreaticoduodenectomy (2013) (79)
Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients (2016) (78)
Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. (2013) (77)
Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. (2013) (74)
Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization. (2017) (74)
Electronic synoptic operative reporting: assessing the reliability and completeness of synoptic reports for pancreatic resection. (2010) (74)
Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract (2009) (74)
Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer. (2007) (74)
Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma (2017) (74)
Prospective Study of Outcomes after Percutaneous Biliary Drainage for Malignant Biliary Obstruction (2010) (73)
Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection (2015) (73)
The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas (2006) (73)
T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases. (2010) (72)
Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. (2005) (72)
Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response (2011) (72)
Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients. (2018) (70)
Endoscopic ultrasound-guided transmural drainage of postoperative pancreatic collections. (2014) (70)
Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. (2016) (70)
The role of laparoscopic staging in patients with incidental gallbladder cancer. (2011) (69)
Failure Patterns in Resected Pancreas Adenocarcinoma: Lack of Predicted Benefit to SMAD4 Expression (2013) (69)
The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer (2018) (68)
Synchronous Resection of Primary and Liver Metastases for Neuroendocrine Tumors (2012) (67)
Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases (2014) (67)
Caudate hepatectomy for cancer: a single institution experience with 150 patients. (2005) (67)
Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas. (2007) (66)
Management of peripancreatic fluid collections following partial pancreatectomy: a comparison of percutaneous versus EUS-guided drainage (2013) (66)
Pathologic Grade and Tumor Size are Associated with Recurrence-Free Survival in Patients with Duodenal Neuroendocrine Tumors (2014) (65)
Profile of Plasma Angiogenic Factors Before and After Hepatectomy for Colorectal Cancer Liver Metastases (2006) (64)
Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? (2005) (64)
Updated long‐term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy (2016) (64)
Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. (2006) (63)
Liver metastases (2021) (61)
Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models. (2015) (61)
Biliary Sclerosis after Hepatic Arterial Infusion Pump Chemotherapy for Patients with Colorectal Cancer Liver Metastasis: Incidence, Clinical Features, and Risk Factors (2012) (60)
Surgical management of hepatic metastases of colorectal cancer. (2015) (60)
Liver planning software accurately predicts postoperative liver volume and measures early regeneration. (2014) (59)
Resection of Adrenocortical Carcinoma Liver Metastasis: Is it Justified? (2012) (59)
Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver Metastases: A Review. (2019) (59)
Differential diagnosis of proximal biliary obstruction. (2006) (59)
Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. (2014) (59)
Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement. (2013) (58)
Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. (2003) (58)
Pathologic Response to Preoperative Chemotherapy in Colorectal Liver Metastases: Fibrosis, not Necrosis, Predicts Outcome (2012) (58)
Goal-Directed Fluid Therapy Using Stroke Volume Variation for Resuscitation after Low Central Venous Pressure-Assisted Liver Resection: A Randomized Clinical Trial. (2015) (58)
Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results (2011) (58)
Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome (2017) (58)
Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort (2017) (55)
Optimal Abdominal Incision for Partial Hepatectomy: Increased Late Complications with Mercedes-type Incisions Compared to Extended Right Subcostal Incisions (2006) (54)
The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis. (2012) (53)
Spatial and phenotypic immune profiling of metastatic colon cancer. (2018) (53)
Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer. (2010) (53)
Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. (2013) (53)
Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases (2013) (53)
Predicting recurrence patterns after resection of hepatocellular cancer. (2014) (52)
Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma (2017) (52)
Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. (2017) (51)
Hepatic resection for colorectal metastases (2014) (51)
Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma (2016) (51)
Comparison Between Perioperative and Postoperative Chemotherapy After Potentially Curative Hepatic Resection for Metastatic Colorectal Cancer (2013) (50)
Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer (2019) (50)
Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor (2016) (49)
Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer. (2018) (49)
Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer. (2003) (49)
Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer. (2009) (48)
Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis. (2013) (48)
Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease (2011) (48)
Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential (2018) (48)
Impact of Obesity and Body Fat Distribution on Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma (2012) (48)
Simple measurement of intra-abdominal fat for abdominal surgery outcome prediction. (2010) (47)
CXCR4 Expression Predicts Patient Outcome and Recurrence Patterns after Hepatic Resection for Colorectal Liver Metastases (2012) (46)
Initial experience with hand-assisted laparoscopic distal pancreatectomy (2005) (46)
Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma (2021) (45)
Cytokine-secreting herpes viral mutants effectively treat tumor in a murine metastatic colorectal liver model by oncolytic and T-cell-dependent mechanisms (2007) (45)
Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. (2015) (45)
Tumor MHC Class I Expression Improves the Prognostic Value of T-cell Density in Resected Colorectal Liver Metastases (2014) (45)
Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. (2008) (44)
Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance (2011) (44)
American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions. (2014) (44)
Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer (2017) (44)
Readmission After Pancreatic Resection: Causes and Causality Pattern (2014) (44)
Prospective Randomized Controlled Trial of Liberal Vs Restricted Perioperative Fluid Management in Patients Undergoing Pancreatectomy (2016) (44)
Meeting the biologic challenge of colorectal metastases (2012) (43)
Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage (2015) (43)
Patterns of Recurrence After Ablation of Colorectal Cancer Liver Metastases (2012) (43)
Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes (2015) (43)
Detailed Pathologic Characteristics of the Primary Colorectal Tumor Independently Predict Outcome after Hepatectomy for Metastases (2012) (43)
Isolated Hepatic Splenosis: First Reported Case (1998) (43)
Role of intra‐arterial hepatic chemotherapy in the treatment of colorectal cancer metastases (2010) (43)
Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single Institution (2017) (43)
Hepatic Pedicle Clamping During Hepatic Resection for Colorectal Liver Metastases: No Impact on Survival or Hepatic Recurrence (2012) (42)
Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases (2015) (42)
The use of imaging in the diagnosis and staging of hepatobiliary malignancies. (2007) (42)
Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. (2009) (42)
Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice? (2020) (41)
Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon. (1997) (41)
Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease (2015) (41)
Renal function after low central venous pressure-assisted liver resection: assessment of 2116 cases. (2015) (40)
Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes. (2015) (39)
Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution (2013) (38)
Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies (2016) (38)
Treatment of liver colorectal metastases: Role of laparoscopy, radiofrequency ablation, and microwave coagulation (2010) (38)
Synchronous Hepatic Metastases from Colon Cancer: Changing Treatment Strategies and Results of Surgical Intervention (2009) (38)
Positive Postoperative CEA is a Strong Predictor of Recurrence for Patients After Resection for Colorectal Liver Metastases (2015) (37)
Perihepatic Lymph Node Micrometastases Impact Outcome after Partial Hepatectomy for Colorectal Metastases (2008) (36)
Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas (2017) (36)
The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial (2017) (36)
Anastomotic Leak Following Low Anterior Resection in Stage IV Rectal Cancer is Associated with Poor Survival (2013) (36)
Floxuridine Hepatic Arterial Infusion Associated Biliary Toxicity Is Increased by Concurrent Administration of Systemic Bevacizumab (2014) (36)
A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases (2016) (35)
Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial (2016) (35)
Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis. (2013) (35)
Changes in the management of benign liver tumours: an analysis of 285 patients. (2013) (34)
Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases (2017) (34)
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors (2019) (34)
Resectable Hilar Cholangiocarcinoma: Surgical Treatment and Long-Term Outcome (2004) (34)
Impact of pre-operative positron emission tomography in gallbladder cancer. (2014) (34)
Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis. (2019) (33)
Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. (2012) (33)
Regional Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Potential Role for Dynamic Magnetic Resonance Imaging as an Imaging Biomarker and a Survival Update from Two Prospective Clinical Trials (2014) (33)
Factors Associated With Local Tumor Control and Complications After Thermal Ablation of Colorectal Cancer Liver Metastases: A 15-year Retrospective Cohort Study. (2020) (33)
Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer (2012) (33)
CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma (2019) (32)
Kinetics of liver volume changes in the first year after portal vein embolization. (2010) (32)
Clinical Features and Outcome of Primary Pancreatic Lymphoma (2015) (32)
Regional differences in gallbladder cancer pathogenesis: Insights from a multi‐institutional comparison of tumor mutations (2018) (31)
Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases (2008) (31)
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma. (2020) (31)
Surgeon-patient communication in the treatment of pancreatic cancer. (1998) (30)
Recurrence patterns following irreversible electroporation for hepatic malignancies (2017) (30)
Management and extent of resection for intrahepatic cholangiocarcinoma. (2009) (30)
Incidentally Discovered Pancreatic Intraepithelial Neoplasia: What Is Its Clinical Significance? (2013) (29)
Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation. (2016) (29)
Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer. (2014) (29)
Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection. (2017) (29)
Genetic Evidence That Intratumoral T-cell Proliferation and Activation Are Associated with Recurrence and Survival in Patients with Resected Colorectal Liver Metastases (2015) (29)
Gene Expression Profiles Accurately Predict Outcome Following Liver Resection in Patients with Metastatic Colorectal Cancer (2013) (29)
Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. (2016) (28)
Treatment of Extensive Metastatic Colorectal Cancer to the Liver with Systemic and Hepatic Arterial Infusion Chemotherapy and Two-Stage Hepatic Resection: The Role of Salvage Therapy for Recurrent Disease (2014) (28)
Selective use of diagnostic laparoscopy prior to planned hepatectomy for patients with hepatocellular carcinoma. (2004) (28)
Program and candidate experience with virtual interviews for the 2020 Complex General Surgical Oncology interview season during the COVID pandemic. (2020) (27)
Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation (2015) (27)
Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer (2019) (27)
Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing (2018) (27)
Pitfalls in avoiding operation for autoimmune pancreatitis. (2011) (25)
Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer. (2006) (25)
Surgical management of biliary tract cancers. (2016) (25)
Timing of elective surgery as a perioperative outcome variable: analysis of pancreaticoduodenectomy. (2014) (25)
Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN) (2018) (24)
Laparoscopic Liver Resection Difficulty Score—a Validation Study (2018) (23)
Extrahepatic bile duct carcinoid tumors: malignant biliary obstruction with a good prognosis. (2007) (22)
Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative procedures and in-hospital days? (2012) (22)
A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients (2016) (22)
Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial (2019) (21)
Operative morbidity and survival following hepatectomy for colorectal liver metastasis in octogenarians: a contemporary case matched series. (2016) (21)
Hepatic Arterial Nodal Metastases in Pancreatic Cancer: Is This the Node of Importance? (2013) (21)
Hepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancer. (2015) (21)
Staging laparoscopy for potentially resectable noncolorectal, nonneuroendocrine liver metastases (2002) (20)
Herpes Simplex Virus (HSV)-Mediated ICAM-1 Gene Transfer Abrogates Tumorigenicity and Induces Anti-Tumor Immunity (1999) (20)
Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies (2017) (20)
Outcomes of the Memorial Sloan Kettering Cancer Center International General Surgical Oncology Fellowship. (2016) (20)
Pharmacologic Prophylaxis, Postoperative INR, and Risk of Venous Thromboembolism after Hepatectomy (2014) (20)
Liver resection and ablation for metastatic melanoma: A single center experience (2015) (20)
MicroRNA-203 predicts human survival after resection of colorectal liver metastasis (2016) (20)
The effects of hepatic cryosurgery on tumor growth in the liver. (1998) (20)
Cystic lesions of the pancreas: Selection criteria for operative and non-operative management in 209 patients (2003) (20)
Outcomes after Pancreatectomy with Routine Pasireotide Use. (2019) (19)
In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors (1999) (19)
Adrenal Metastasectomy in the Presence and Absence of Extraadrenal Metastatic Disease. (2019) (19)
Central hepatectomy versus extended hepatectomy for liver malignancy: a matched cohort comparison. (2015) (19)
Surgical Management of Hepatobiliary and Pancreatic Disorders (2003) (19)
Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study (2021) (18)
High-grade dysplasia of the cystic duct margin in the absence of malignancy after cholecystectomy. (2011) (18)
A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years (2009) (18)
Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. (2013) (18)
A Survey of the Complex General Surgical Oncology Fellowship Programs Regarding Applicant Selection and Rank (2019) (18)
Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance ? luated at a Single Institution Results of 3024 Patients (2017) (18)
Laparoscopic staging for liver, biliary, pancreas, and gastric cancer. (2007) (17)
Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases (2019) (17)
Histopathological growth patterns and positive margins after resection of colorectal liver metastases. (2018) (17)
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection (2021) (17)
Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. (2019) (16)
The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma. (2017) (16)
Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells (2019) (16)
Anatomy of Hepatic Resectional Surgery. (2016) (16)
Hepatic arterial infusional chemotherapy in the management of colorectal cancer liver metastases. (2015) (16)
Comparative Analysis of Outcome in Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria Treated With Liver Transplantation Versus Partial Hepatectomy (2011) (16)
c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival. (2013) (16)
Liver resection after hepatic arterial infusion (HAI) plus systemic oxaliplatin (Oxal) combinations in pretreated patients with extensive unresectable colorectal liver metastases (2004) (16)
Autologous Versus Allogeneic Transfusions: No Difference in Perioperative Outcome After Partial Hepatectomy (2007) (16)
Efficient cotransduction of tumors by multiple herpes simplex vectors: Implications for tumor vaccine production (2000) (15)
Hepatic artery infusion pumps (2020) (15)
Angiographic identification of extrahepatic perfusion after hepatic arterial pump placement: implications for surgical prevention. (2014) (15)
Early trends in serum phosphate and creatinine levels are associated with mortality following major hepatectomy. (2015) (14)
Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide Phosphoribosyltransferase. (2017) (14)
Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights (2022) (14)
Hospital readmissions after liver surgery for metastatic colorectal cancer. (2015) (14)
Robotic hepatic arterial infusion pump placement. (2017) (14)
Spatial mapping of the collagen distribution in human and mouse tissues by force volume atomic force microscopy (2020) (13)
Uncinate Duct Dilation in Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Radiographic Finding with Potentially Increased Malignant Potential (2014) (13)
Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma. (2022) (13)
Patient selection for hepatic resection for metastatic colorectal cancer. (2012) (13)
3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: results from a prospective trial. (2017) (13)
Selecting patients for acute normovolemic hemodilution during hepatic resection: a prospective randomized evaluation of nomogram-based allocation. (2013) (13)
Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study. (2019) (13)
Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection. (2019) (13)
The accuracy of pre-operative imaging in the management of hepatic cysts. (2015) (13)
Radiation segmentectomy of hepatic metastases with Y-90 glass microspheres (2021) (12)
Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma (2021) (12)
Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach? (2019) (12)
Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis (2018) (12)
Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer (2016) (12)
The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma (2016) (12)
Gallbladder Cancer: Managing the Incidental Diagnosis. (2019) (12)
HPB Surgery: The Specialty is Here to Stay, but the Training is in Evolution (2016) (12)
Treatment sequencing for simultaneous colorectal liver metastases (2019) (12)
Regional Differences in Gallbladder Cancer Pathogenesis: Insights from a Comparison of Cell Cycle-Regulatory, PI3K, and Pro-Angiogenic Protein Expression (2013) (11)
Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer (2020) (11)
Risk of Occult Irresectable Disease at Liver Resection for Hepatic Colorectal Cancer Metastases: A Contemporary Analysis (2013) (11)
Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease (2015) (11)
A perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resection. (2019) (11)
Recurrence Patterns of Intraductal Papillary Mucinous Neoplasms of the Pancreas on Enhanced Computed Tomography (2009) (11)
Survey of Surgical Oncology Fellowship Graduates 2005–2016: Insight into Initial Practice (2019) (11)
Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution. (2019) (11)
Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease (2012) (10)
Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases (2021) (10)
Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study (2020) (10)
Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases. (2022) (10)
Resection of perihilar biliary schwannoma. (2011) (10)
Use of Intraoperative Ablation as an Adjunct to Surgical Resection in the Treatment of Recurrent Colorectal Liver Metastases (2011) (10)
Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery Chemotherapy (2020) (10)
En bloc resection of diaphragm with lung for recurrent ovarian cancer: a case report. (2006) (10)
A Call for Caution in Overinterpreting Exceptional Outcomes Following Radical Surgery for Pancreatic Cancer: Let the Data Speak. (2020) (10)
A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma (2018) (10)
The Randomized Registry Trial: Two Birds, One Stone. (2017) (10)
Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis. (2022) (9)
Intrahepatic and Extrahepatic Biliary Cancer (2007) (9)
Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases (2018) (9)
A quantitative assessment of liver metabolites during jaundice using three dimensional phosphorus chemical shift imaging. (2000) (9)
Unexpected increased biliary toxicity when systemic bevacizumab is added to hepatic arterial infusion. (2010) (9)
Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging. (2018) (9)
Extending the Limits of Resection for Colorectal Liver Metastases: Positive Resection Margin and Outcome After Resection of Colorectal Cancer Liver Metastases (2016) (9)
Treatment patterns and survival in patients with early‐onset pancreatic cancer (2021) (9)
Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1H MRS study (2013) (8)
Liver transplantation for colorectal liver metastasis (2019) (8)
Assessing splenic enlargement on CT by unidimensional measurement changes in patients with colorectal liver metastases (2015) (8)
Is neoadjuvant (neoadj) treatment necessary prior to liver resection in patients with resectable liver metastases (mets) from colorectal carcinoma (CRC) treated with post-resection hepatic arterial infusion (HAI) plus systemic (SYS) chemotherapy (2007) (8)
Local Control and Survival After Induction Chemotherapy and Ablative Radiation Versus Resection for Pancreatic Ductal Adenocarcinoma With Vascular Involvement (2021) (8)
Liver and Bile Duct Cancer (2020) (8)
Synoptic operative reporting for laparoscopic cholecystectomy and pancreaticoduodenectomy: A multi institutional pilot study evaluating completeness and surgeon perceptions. (2018) (8)
Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy (2020) (7)
Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases (2022) (7)
Genomic stratification beyond Ras/B‐Raf in colorectal liver metastasis patients treated with hepatic arterial infusion (2019) (7)
Recurrent invasive intraductal papillary mucinous carcinoma of the pancreas mimicking pott disease: review of the literature. (2006) (7)
Systemic Therapy for Patients with Resectable Hepatic Colorectal Metastases: Improving Patient Selection (2013) (7)
Prognostic Significance of the Highest Peripancreatic Lymph Node in Biliary Tract Adenocarcinoma (2014) (7)
Locoregional Therapy for Hepatocellular Carcinoma with and without Extrahepatic Spread. (2015) (7)
Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers (2012) (7)
Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? (2022) (7)
Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas (2017) (7)
Defining the risk of liver failure after minor hepatectomy: a NSQIP analysis of 7029 patients. (2020) (7)
Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms (2020) (7)
Training Paradigms in Hepato-Pancreatico-Biliary Surgery: an Overview of the Different Fellowship Pathways (2021) (7)
Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. (2012) (7)
Liver angiomyolipomas: a clinical, radiologic, and pathologic analysis of 22 patients from a single center. (2011) (7)
Intra-arterial Chemotherapy for Liver Tumors (2007) (6)
A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC). (2018) (6)
Current role of therapeutic laparoscopy and thoracoscopy in the management of malignancy: a review of trends from a tertiary care cancer center. (2008) (6)
Symptomatic Perihepatic Fluid Collections After Hepatic Resection in the Modern Era (2016) (6)
Association of preoperative biliary drainage technique with postoperative outcomes among patients with resectable hepatobiliary malignancy. (2020) (6)
Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases (2020) (6)
Cytokine gene therapy for human tumors. (1998) (6)
Hepatocellular adenoma among adult survivors of childhood and young adult cancer (2017) (6)
Surgical salvage of recurrence after resection of colorectal liver metastases: incidence and outcomes. (2017) (6)
An update on randomized clinical trials in advanced and metastatic colorectal carcinoma. (2010) (6)
Hepatic arterial infusion chemotherapy for metastases from colorectal cancer: is it really the end of an era? (2008) (6)
The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases. (2019) (6)
Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas (2017) (6)
Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy (2020) (6)
Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases (2018) (6)
Phase I trial of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (DEX) in combination with systemic oxaliplatin (OXAL), fluorouracil (FU) + leucovorin (LV) after resection of hepatic metastases from colorectal cancer (2005) (6)
Hepatic steatosis is associated with increased complications following major liver resection for cancer but does not impact survival (2003) (6)
An outlook on precision surgery. (2017) (6)
What Is Riskier for the Patient with an Asymptomatic Large Hepatic Hemangioma: Observation or the Surgeon? (2013) (6)
Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation. (2013) (6)
Getting Chemotherapy Directly to the Liver: The Historical Evolution of Hepatic Artery Chemotherapy. (2020) (5)
Hepatic resection for metastatic breast cancer: an exercise in selection bias. (2016) (5)
Expression of the c-met and HGF in resected hepatocellular carcinoma (rHCC): Correlation with clinicopathological features (CP) and overall survival (OS) (2008) (5)
Metastatic Colorectal Cancer to the Liver: Involve the Surgeon Early and Often (2015) (5)
Cancer of the bile ducts: Extrahepatic biliary tumors (2012) (5)
Liver resection after hepatic arterial infusion (HAI) plus systemic oxaliplatin (Oxal) combinations in pretreated patients with extensive unresectable colorectal liver metastases. (2004) (5)
Positive Margins After Resection of Metastatic Colorectal Cancer in the Liver: Back to the Drawing Board? (2017) (5)
Malignant progression in intraductal papillary mucinous neoplasms of the pancreas: Results of 157 patients selected for radiographic surveillance. (2012) (5)
Can physician gestalt predict survival in patients with resectable pancreatic adenocarcinoma? (2018) (5)
Cefoxitin versus piperacillin–tazobactam as surgical antibiotic prophylaxis in patients undergoing pancreatoduodenectomy: protocol for a randomised controlled trial (2021) (5)
Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients (2018) (5)
Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases (2019) (5)
Surgical Management of Colorectal Cancer Liver Metastases. (2021) (5)
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases. (2015) (4)
Timing of Complication and Failure to Rescue after Hepatectomy: Single-Institution Analysis of 28-Years of Hepatic Surgery. (2021) (4)
Intraductal papillary neoplasm of the bile duct (IPNB): A biliary equivalent to IPMN of the pancreas? (2011) (4)
Survival after resection of liver metastases from colorectal cancer with poor clinical risk factors using adjuvant systemic plus hepatic arterial therapy (2008) (4)
Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy. (2017) (4)
Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional study. (2020) (4)
Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care (2021) (4)
The Interplay of Primary Tumor Location and KRAS Mutation Status in Patients with Synchronous Colorectal Cancer Liver Metastases: Current Data and Unanswered Questions (2020) (4)
Consensus conference on intrahepatic cholangiocarcinoma. (2015) (3)
Biliary-Enteric Anastomosis (2007) (3)
Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. (2020) (3)
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions (2014) (3)
Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla (2014) (3)
Are patients with multiple hepatic metastases from colorectal cancer candidates for surgery? (2007) (3)
Lending a hand for laparoscopic distal pancreatectomy: the optimal approach? (2019) (3)
Demystifying BRAF Mutation Status in Colorectal Liver Metastases: A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions. (2022) (3)
Levels of Evidence in Medical Research: "Bigger Is Not Always Better". (2017) (3)
Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery (2020) (3)
Survival after resection plus intra-operative radiofrequency ablation (IRFA) to treat colorectal liver metastases (CLM): Results of an international collaborative study. (2013) (3)
Prospective Phase II Trial of Combination Hepatic Artery and Systemic Chemotherapy for Unresectable Colorectal Liver Metastases: Long-Term Results and Curative Potential (2016) (3)
Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver‐related mortality (2020) (3)
Radiofrequency-assisted Hepatectomy May Induce Severe Postoperative Liver Damage (2007) (3)
Hepatic arterial infusion (HAI) therapy in patients with unresectable primary liver cancer: Use of dynamic contrast enhanced MRI to evaluate response (2005) (3)
Predictors of a true complete response in colorectal liver metastases that disappear radiographically following chemotherapy (2007) (3)
Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy (2022) (3)
Right versus left: Impact of primary location on survival and cure in patients undergoing hepatic resection for metastatic colon cancer. (2017) (3)
Early liver metastases after "failure" of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy? (2020) (3)
Multiinstitutional Validation Study of Cyst Fluid Protein Biomarkers in Patients With Cystic Lesions of the Pancreas (2021) (2)
Chapter 29 – Bile duct exploration and biliary-enteric anastomosis (2012) (2)
Hepatic artery therapies for unresectable colorectal liver metastases: Pooled survival analysis of 968 patients from TACE, yttrium-90, and HAI studies. (2017) (2)
Embolization with microspheres alone for hepatocellular carcinoma with portal vein tumor: analysis of outcome and liver function at disease progression. (2020) (2)
Use of T-cell proliferation to predict survival and recurrence in patients with resected colorectal liver metastases. (2010) (2)
Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence–Based Model (2021) (2)
Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention. (2016) (2)
Complications of Intra-Arterial Regional Liver Therapy (2019) (2)
Genomic Stratification of Resectable Colorectal Liver Metastasis Patients and Implications for Adjuvant Therapy and Survival (2021) (2)
T1583 A Matched Case-Control Study of Preoperative Biliary Drainage (PDB) in Patients with Pancreatic Adenocarcinoma: Routine PBD Is Not Justified (2009) (2)
Chemotherapy-Associated Hepatotoxicity and Hepatic Resection for Metastatic Colorectal Cancer (2014) (2)
Machine learning radiomics can predict early liver recurrence after resection of intrahepatic cholangiocarcinoma. (2022) (2)
Hepatic resection planning in the modern era: in reply to Mise and colleagues. (2014) (2)
Association of KRAS mutation with worse recurrence-free survival and site of metastatic progression after resection of hepatic colorectal metastases. (2013) (2)
Percutaneous liver venous deprivation: outcomes in heavily pretreated metastatic colorectal cancer patients. (2021) (2)
Response rates to hepatic arterial infusion (HAI) pump therapy in patients with metastatic colorectal cancer liver metastases (mCRC LM) after progression on all standard chemotherapies. (2014) (2)
Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network. (2022) (2)
Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement (2021) (2)
Surgical management of biliary malignancy. (2020) (2)
Improvement in long-term survival in patients with metastatic colorectal cancer (CRC) after liver resection with modern chemotherapy and hepatic arterial infusion (HAI). (2015) (2)
Invasive central venous monitoring during hepatic resection: unnecessary for most patients. (2019) (2)
Mutational profiling of resected intrahepatic cholangiocarcinoma. (2017) (2)
148 Biliary Self Expandable Metal Stents Do Not Increase Overall Complications in Patients Undergoing Pancreaticoduodenectomy (2012) (2)
A combined radiomics and cyst fluid inflammatory markers model to predict preoperative risk in pancreatic cystic lesions (2020) (1)
Use of detailed pathologic characteristics of the primary colorectal tumor to predict outcome after hepatectomy for metastases. (2012) (1)
Staging Stage IV Colorectal Cancer (2013) (1)
Endoscopic versus percutaneous drainage of post-operative fluid collection following pancreatic resection (2017) (1)
Change in circulating tumor DNA after hepatic resection for metastatic colorectal cancer (2018) (1)
Postoperative mortality after liver resection for perihilar cholangiocarcinoma: Importance of biliary drainage of the future liver remnant and development of a risk score (2016) (1)
Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinoma (2022) (1)
Abstract 579: Immune features and neoantigen recognition in mismatch repair-proficient colorectal cancer liver metastases (2019) (1)
Alterations in Somatic Driver Genes Are Associated with Response to Neoadjuvant FOLFIRINOX in Patients with Localized Pancreatic Ductal Adenocarcinoma. (2022) (1)
Survival in Patients with Intrahepatic Cholangiocarcinoma and Positive Lymph Nodes: No Benefit of Resection over Hepatic Arterial Infusion Chemotherapy (2020) (1)
Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1H MRS study (2014) (1)
Two-stage hepatectomy for colorectal liver metastases: A multi-institutional retrospective review. (2017) (1)
Triple rendezvous using percutaneous, endoscopic, and real-time CT to safely reanastomose bile duct transection following liver resection (2014) (1)
Segmental vs. Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection. (2022) (1)
ASO Author Reflections: Primary Tumor Location and Long-Term Survival After Hepatic Resection for Metastatic Colon Cancer (2018) (1)
Laparoscopic partial hepatectomy (2005) (1)
Dynamic contrast enhanced MRI (DCE-MRI) to measure antiangiogenic therapy and predict treatment response in primary liver cancer (PLC). (2010) (1)
Chapter 49 – Cancer of the gallbladder (2012) (1)
Metastatic Liver Tumors: The Path to Disease-Free Survival. (2021) (1)
The Ligamentum Teres Approach and Other Approaches to the Intrahepatic Ducts for Palliative Bypass (2007) (1)
Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial Embolization: A Retrospective Study on Patterns, Treatments, and Prognoses (2022) (1)
QS224. Genome Wide Analysis and Clinical Correlation of Chromosomal and Transcriptional Mutations in Cancers of the Biliary Tract (2008) (1)
Percutaneous microwave ablation for colorectal cancer liver metastasis: initial results (2014) (1)
Intraoperative Injury to Hepatic Arterial Structures (2015) (1)
Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients (2020) (1)
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial. (2023) (1)
Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade (2022) (1)
Influence of KRAS mutation on recurrence patterns in patients undergoing hepatic resection of colorectal metastases. (2013) (1)
Surgical therapy and survival prospects in hilar cholangiocarcinoma (2003) (1)
Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adenocarcinoma (2021) (1)
Abstract 2444: The use of CT radiomics to predict immune infiltrate in pancreatic ductal adenocarcinoma (2019) (1)
Hepatic Artery Infusion Therapy for Colorectal Cancer Liver Metastases (2018) (1)
Clinical/pathologic features and survival of patients with fibrolamellar-hepatocellular carcinoma (FLL-HCC): Data from the Fibrolamellar-Hepatocellular (FLL-HCC) Consortium. (2011) (1)
Is conversion to resection possible with hepatic arterial infusion (HAI) and systemic (SYS) even in previously treated patients (pts) with unresectable colorectal liver metastases (UnCLM) (2012) (1)
Infiltrating neutrophils and malignant progression in intraductal papillary mucinous neoplasms (IPMN): An opportunity for identification of high-risk disease. (2014) (1)
Registry‐based randomized clinical trials in surgery: Working with ACS‐NSQIP and the AHPBA to conduct pragmatic trials (2021) (1)
A Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Therapy With or Without Panitumumab After Hepatic Resection of KRAS Wild-type Colorectal Cancer (2021) (1)
Association of genomic profiles and survival in early onset and screening‐age colorectal cancer patients with liver metastases resected over 15 years (2022) (1)
Transient ischemic-reperfusion injury of the liver promotes tumor growth by modulation of arginine metabolism and suppresion of immune function (1998) (1)
Effect of perioperative complications on recurrence and survival after resection of hepatic colorectal metastases: Analysis of data from a randomized controlled trial. (2012) (1)
Hepatic arterial infusion (HAI) chemotherapy via the medtronic pump-assessing dose delivery, response rates and toxicity. (2020) (1)
Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma (2021) (1)
A Multi-Institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-Grade Dysplasia in Intraductal Papillary Mucinous Neoplasms (2016) (1)
Prognostic Markers and Staging Systems for Patients with Colorectal Liver Metastases (2011) (1)
Laparoscopic liver resection. (2012) (1)
Patterns of failure in patients with resectable synchronous liver metastases from rectal cancer (SLMRC): An analysis of the outcomes with and without pelvic radiotherapy. (2011) (1)
FOLFIRINOX induction therapy for stage III pancreatic adenocarcinoma (2014) (1)
80 – Liver and Bile Duct Cancer (2014) (1)
Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results? (2011) (1)
Modern Locoregional Treatment of Colorectal Cancer Liver Metastases (2016) (1)
Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastases (2020) (1)
Hepatic Artery Infusion Pumps (2022) (1)
Hepatocellular carcinoma in patients with no identifiable risk factors. (2019) (1)
Adjuvant hepatic arterial infusion chemotherapy is associated with superior survival after resection of colorectal liver metastases: A propensity score analysis of 2368 patients (2016) (0)
ASO Author Reflections: Upfront Surgery for Resectable Colorectal Liver Metastases: Biology is (Still) King (2023) (0)
Adequate lymph node assessment for extrahepatic bile duct cancer: Do the data support the current AJCC recommendations? (2009) (0)
Spectrum and outcome of repair of benign biliary strictures (2003) (0)
Colorectal Cancer: Metastatic (Palliation) (2007) (0)
Regional differences in gallbladder cancer pathogenesis: Insights from a comparison of tumor mutations (2018) (0)
Poor prognosis in patients with resectable KRAS-MUT colorectal liver metastases is improved by adjuvant hepatic arterial infusion chemotherapy. (2017) (0)
Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases; results of a safety and feasibility study in the Netherlands (2020) (0)
A multicentre analysis on the impact of primary tumour location in patients undergoing surgery for colorectal liver metastasis. (2019) (0)
916 Tumor Grade, Not Extent of Resection, Is Associated With Recurrence-Free Survival in Patients With Duodenal Neuroendocrine Tumors (2013) (0)
Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases; a phase II trial (2020) (0)
Circulating CD133: A Promising Biomarker, but What Are We Measuring? (2012) (0)
Longitudinal follow-up of a prospective phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma reveals distinct patterns of survivorship (2019) (0)
肝部分切除术理想的手术切口:Mercedes型切口远期并发症较扩大右肋缘下切口增加 (2006) (0)
913 Pharmacologic Prophylaxis, Postoperative INR, and Risk of Venous Thromboembolism After Hepatectomy (2013) (0)
Issue Information ‐ TOC (2016) (0)
Symptomatic perihepatic collections after hepatic resection in the modern era (2014) (0)
Health-related quality of life (HRQoL) following pancreatic resection in RCT of pasireotide. (2014) (0)
Percutaneous radiofrequency ablation of colorectal cancer liver Metastases: Factors Affecting Outcomes—A 10-year Experience at a Single Center 1 (2016) (0)
Long-termOutcomes Following Tumor Ablation for Treatment of Bilateral Colorectal LiverMetastases (2013) (0)
Multidisciplinary, perioperative care bundle decreases surgical site infection in patients undergoing synchronous colorectal/liver resection (2018) (0)
Minimally invasive versus open segment 7 and 8 hepatic resection: a propensity score-matched comparison (2017) (0)
Use of CXCR4 as a prognostic marker for disease-specific survival and pattern of recurrence following resection of hepatic colorectal metastases. (2009) (0)
Resection of parenchymal liver metastases in patients with uterine malignancies (2019) (0)
Is PET scan conversion from positive to negative a prognostic indicator for patients receiving therapy for unresectable liver metastases from colorectal carcinoma (CRC)? (2011) (0)
Conversion to complete surgical treatment using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer. (2012) (0)
Sa1487 Direct Percutaneous Endoscopic Jejunostomy for Management of Severe Delayed Gastric Emptying Following Pancreatoduodenectomy (2015) (0)
Hepatic adenoma among adult survivors of childhood cancer. (2016) (0)
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival. (2023) (0)
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy (2022) (0)
Role of biliary CEACAM6 as a biomarker for cholangiocarcinoma. (2013) (0)
Hepatic arterial infusion for unresectable intrahepatic cholangiocarcinoma: An update on survival from two prospective clinical trials. (2013) (0)
488 Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection vs. Observation (2015) (0)
– BONE AND SOFT TISSUE SARCOMAS Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor (2019) (0)
An analysis of the extent of hepatectomy for adenocarcinoma of the gallbladder (2005) (0)
Concordance in oncogenic alterations between primary and recurrent/metastatic cholangiocarcinoma pairs using targeted next-generation sequencing. (2023) (0)
utcomes after Resection of Synchronous r Metachronous Hepatic and Pulmonary olorectal Metastases (2007) (0)
Radioembolization as a salvage therapy for heavily pre-treated patients with colorectal cancer liver metastases: factors affecting outcomes (2016) (0)
Re : Interferon : The Magic Bullet to Prevent Hepatocellular Carcinoma Recurrence After Resection ? (0)
Immediate post-thermal ablation biopsy of colorectal liver metastases to predict oncologic outcomes. (2020) (0)
Reply to H. Zhang et al. (2013) (0)
AHPBA Webinar about Covid-19: lessons learned responding to a pandemic (2020) (0)
Evaluation of the Implementation of Enhanced Recovery after Surgery Pathways in Pancreatic Surgery (2022) (0)
Microwave Ablation (MWA) for the Treatment of a Solitary, Chemorefractory Testicular Cancer Liver Metastasis (2015) (0)
M1501 Polypoid Lesions of Gallbladder: Diagnosis and Follow-Up (2008) (0)
1325 Regulation of Tissue factor (TF) in colorectal cancer: association with KRAS (2009) (0)
The management of small asymptomatic pancreatic neuroendocrine tumors: A matched case-control study. (2015) (0)
Alterations in Driver Genes Are Associated with Response to Neoadjuvant Folfirinox in Patients with Nonmetastatic Pancreatic Ductal Adenocarcinoma (2021) (0)
Behind the cyst: predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) by quantitative image analysis (2017) (0)
Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients (2018) (0)
Meeting the biologic challenge of colorectal metastases (2012) (0)
Gene expression profiles to predict outcome following liver resection in patients with metastasis of colorectal cancer. (2010) (0)
Abstract A040: CT Radiomics to predict early recurrence of margin-negative resectable pancreatic ductal adenocarcinoma (2022) (0)
Hospital variation in use of prophylactic drains following hepatectomy. (2020) (0)
Computerized Diagnosis of Liver Tumors From CT Scans Using a Deep Neural Network Approach (2023) (0)
Intra-Arterial Therapy for Unresectable Colorectal Liver Metastases: Which and When? A Commentary on "Intra-Arterial Therapy for Unresectable Colorectal Liver Metastases: A Meta-Analysis". (2021) (0)
A Prospective Cohort Study of a Perioperative Bundle to Reduce Surgical Site Infection following Pancreaticoduodenectomy (2021) (0)
Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC). (2011) (0)
Su1530 Robotic Hepatic Artery Infusion Pump Placement (2016) (0)
Association of adjuvant hepatic artery infusion chemotherapy after resection of colorectal liver metastases with improved survival in patients with both right- and left-sided primary tumors. (2018) (0)
Improved mortality after pancreatectomy in the modern era (2018) (0)
Outcomes after pancreatectomy with routine usage of pasireotide (2018) (0)
W1668 The use of Intraoperative Ablation Extends the Limits of Potentially Curative Treatment for Recurrent Colorectal Liver Metastases (2010) (0)
AB005. S005. A multiinstitutional postoperative nomogram for disease recurrence following resection of localized G1/G2 pancreatic neuroendocrine tumors (2018) (0)
Intra-Arterial Chemotherapy (2017) (0)
Pathology remains the most important predictor of long-term survival using a modern prognostic nomogram for resected pancreatic ductal adenocarcinoma (2019) (0)
Cell Cycle Regulatory Protein Expression in Biliary Tract Adenocarcinoma (2005) (0)
Timing of perioperative chemotherapy in the surgical treatment of colorectal liver metastases: a propensity score matched analysis (2020) (0)
Hepatobiliary Cancers Clinical Practice Guidelines in OncologyTM (2009) (0)
Incidence and risk factors for biliary sclerosis following adjuvant hepatic arterial infusion with floxuridine after hepatectomy for metastatic colorectal cancer. (2010) (0)
ASO Author Reflections: Ras-p53 Cooperativity Predicts Recurrence Patterns After Resection of Colorectal Liver Metastases with Adjuvant Local and Systemic Chemotherapy (2022) (0)
ASO Author Reflections: Complex General Surgical Oncology Fellowships: What Are Programs Looking For? (2019) (0)
ASO Visual Abstract: Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement (2022) (0)
Phase II trial of maximal ablative irradiation because of encasement (MAIBE) for patients with potentially resectable locally advanced pancreatic cancer. (2023) (0)
Patterns of recurrence and peri-operative predictors of liver metastasis after pancreatic cancer resection (2018) (0)
Outcomes following transarterial embolization for hepatocellular carcinoma with complete radiologic response (2018) (0)
Comparison of Clinicopathological Characteristics, Protein Expression Profiling and Outcomes in Eastern and Western Patients with Hepatocellular Carcinoma (2005) (0)
Differentiation of mucinous cysts and simple cysts of the liver using preoperative imaging (2022) (0)
ASO Author Reflections: Characterizing the Impact of RAS Mutation Location on Outcomes for Colorectal Liver Metastases (2020) (0)
Genetic heterogeneity of intrahepatic cholangiocarcinoma: Implications for outcome. (2023) (0)
Gallbladder Cancer with Common Bile Duct Invasion (2017) (0)
630 Laparoscopic Versus Open Liver Resection: A Matched-Pair Case Control Study (2009) (0)
1028 Management of Symptomatic Intraabdominal Collections After 672 Hepatic Resections (2009) (0)
Role of Hepatic Artery Infusion Pump Chemotherapy for Unresectable Colorectal Cancer Liver Metastases (2019) (0)
1031 Natural History of Patients Followed Radiographically With Mucinous Cystic Neoplasms of the Pancreas (2016) (0)
Issue Information ‐ TOC (2018) (0)
A retrospective study of hepatic arterial infusion (HAI) FUDR/Dex and mitomycin C (MMC) for chemotherapy refractory unresectable intrahepatic cholangiocarcinomas (ICC). (2019) (0)
Proteomic evaluation of biliary exosomes implicates exportin7 in the pathogenesis of extrahepatic cholangiocarcinoma (2017) (0)
Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy. (2022) (0)
Patient Variability in Intraoperative Ultrasonographic Characteristics of Colorectal Liver Metastases—Invited Critique (2008) (0)
Chapter 85B – Cryoablation for liver tumors (2012) (0)
Safety and Feasibility of Hepatic Artery Infusion Pump Chemotherapy for Unresectable Colorectal Liver Metastases: A Multicenter, Retrospective Cohort Study (2019) (0)
ASO Visual Abstract: Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy (2022) (0)
MHC Class II Expression Influences the Composition and Distribution of Immune Cells in the Metastatic Colorectal Cancer Microenvironment (2022) (0)
Rates and Treatment Patterns of Gallbladder-Related Emergency General Surgery Conditions in the Cancer Population (2022) (0)
Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage. (2023) (0)
Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al. (2017) (0)
Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO). (2023) (0)
Chapter 98D – Cryotherapy and ethanol injection (2017) (0)
Chapter 28 – Quality of life and hepatobiliary tumors (2017) (0)
In Brief (1995) (0)
Comment on Hasselgren K, et al. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442-448. (2021) (0)
Recurrence Patterns after Irreversible Electroporation for Hepatic Metastases (2016) (0)
Significance of CEACAM6 expression in biliary tract carcinoma. (2012) (0)
Advances in the management of liver and biliary tumors (2022) (0)
A palpable pancreatic duct. (2017) (0)
Management of Metastatic Liver Tumors (2021) (0)
Chromosomal instability mediates immune exclusion and response to cytotoxic chemotherapy in colorectal liver metastases (2021) (0)
Extraordinary survivorship after colorectal liver metastasis resection to identify a distinct molecular profile associated with survival in an independent cohort of 965 patients. (2017) (0)
Quality of life in RCT of pasireotide to reduce pancreatic complications following resection. (2015) (0)
ASO Author Reflections: How Immunotherapy Could Change the Management of Responsive Solid Tumors (2022) (0)
Non-alcoholic fatty liver disease is an independent predictor of recurrence after resection of colorectal liver metastases (2019) (0)
Randomized phase II trial of adjuvant hepatic arterial infusion (HAI) + systemic FOLFIRI +/- panitumumab (Pmab) in patients with resected RAS wild type colorectal cancer hepatic metastases (CRLM). (2019) (0)
A 46-Year-Old Asian Woman With Liver Mass. (2015) (0)
Trans-arterial embolization for hepatocellular carcinoma: doxorubicin is not necessary (2016) (0)
The Influence of Patient Preference on Surgeons' Treatment Recommendations in the Management of Intraductal Papillary Mucinous Neoplasms. (2023) (0)
ASO Visual Abstract: Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial embolization: A Retrospective Study on Patterns, Treatments, and Prognosis (2022) (0)
Liver resection. State of the art. (2006) (0)
Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC). (2016) (0)
Abstract No. 107: Radiofrequency ablation of recurrent colorectal cancer hepatic metastases after hepatectomy (2010) (0)
Image of the month. Papillary low-grade neuroendocrine tumor of the pancreas with pancreatic duct dilation. (2005) (0)
ASO Visual Abstract: Recurrence After Resection of Pancreatic Cancer – Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? (2022) (0)
ASO Visual Abstract: A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases (2023) (0)
A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter study. (2022) (0)
Colorectal cancer: a multifaceted disease. (2019) (0)
Risk Perceptions and Risk Thresholds Among Surgeons in the Management of Intraductal Papillary Mucinous Neoplasms (2023) (0)
Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma. (2023) (0)
CT radiomics to predict early hepatic recurrence after resection for intrahepatic cholangiocarcinoma (2022) (0)

This paper list is powered by the following services:

Michael I. D’angelica's Academic­Influence.com Rankings

Why Is Michael I. D’angelica Influential?

Michael I. D’angelica's Published Works

Published Works

Michael I. D’angelica's AcademicInfluence.com Rankings